Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab To Highlight New Data From Its Oncology Pipeline

June 1 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB - EARLY PHASE 1/2 STUDY DATA FROM INTERNALLY
DEVELOPED
ZL-1211 PROGRAM SUPPORT SAFETY/TOLERABILITY PROFILE, PRELIMINARY
ANTITUMOR ACTIVITY

Source text for Eikon:  ID:nGNX6ZXB0p 
Further company coverage:  9688.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news